Business / Finance

RSS

Emergent BioSolutions enters into definitive agreement to acquire Cangene

Emergent BioSolutions Inc.announced that it has entered into a definitive agreement with Cangene Corporation (TSX: CNJ) under which Emergent will acquire all of the outstanding common shares of Cangene in an all-cash transaction valued at $3.24 per share on a fully diluted basis for an aggregate purchase price of $222 million.

12 Dec 2013

Avinger closes significant funding round to initiate clinical trial on peripheral atherectomy catheter

Avinger, Inc. producer of therapeutic devices incorporating intravascular imaging and pioneer of the lumivascular approach to treating vascular disease, announced today the closing of a significant funding round.

12 Dec 2013

Crealta to acquire all assets of Savient Pharmaceuticals

Savient Pharmaceuticals, Inc. ("Savient") announced that it has reached agreement on the terms of an acquisition agreement with Crealta Pharmaceuticals LLC ("Crealta") through which Crealta would acquire substantially all of the assets of Savient, including all KRYSTEXXA® assets, for gross proceeds of approximately $120.4 million.

11 Dec 2013

Pfizer, Octapharma AG to market investigational agent for urgent reversal of vitamin K antagonist

...

11 Dec 2013

Vestiage selects ROI Media for direct to consumer marketing campaign

Vestiage, Inc., a publicly traded healthy aging lifestyle company focused on science-based premium branded highly potent cosmeceuticals and nutraceuticals, announced today that it has engaged ROI Media to orchestrate its direct to consumer marketing campaign.

11 Dec 2013

Broad Medical Research Program, Crohn's & Colitis Foundation of America to merge together

The Broad Medical Research Program, which funds innovative early-stage research into inflammatory bowel disease, will merge with the Crohn's & Colitis Foundation of America, the two organizations announced today.

11 Dec 2013

Patterson Companies announces quarterly cash dividend of $0.16 per share

The Board of Directors of Patterson Companies, Inc., today declared the quarterly cash dividend of $0.16 per share. The dividend will be payable on January 24, 2014, to shareholders of record on January 10, 2014.

11 Dec 2013

Omega Protein proposes to streamline Gulf of Mexico operations

Omega Protein Corporation (NYSE: OME), a nutritional product company and a leading integrated producer of omega-3 fish oil and specialty protein products, today announced a plan to streamline its Gulf of Mexico operations and increase efficiencies through the permanent closure of the Company's menhaden fish processing plant located in Cameron, Louisiana and the redeployment of certain vessels from that plant.

11 Dec 2013

LEC announces consolidated financial results for Q2 2014

Lignol Energy Corporation ("LEC" or "the Company"), a leading technology company in the advanced biofuels and renewable chemicals sector, today announced its unaudited consolidated financial results for the three months and six months ended October 31, 2013 (all figures in Canadian dollars, unless otherwise noted).

11 Dec 2013

Echo Therapeutics signs strategic collaboration agreement with MTIA

Echo Therapeutics, Inc., a medical device company developing its Symphony CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it entered into a strategic collaboration agreement with Medical Technologies Innovation Asia, Ltd., Hong Kong, for a license arrangement and equity investment in Echo.

10 Dec 2013

INVISTA joins CPI for development of new technologies to enable gas-fermentation-based processes

INVISTA and The Centre for Process Innovation (CPI) announce a collaboration for the development of new technologies to enable gas-fermentation-based processes for the production of industrial chemicals.

10 Dec 2013

Methodist Health System joins with IBM Watson and MD Buyline to enable better patient care

Methodist Health System, a premier healthcare provider in the Dallas-Fort Worth area, will leverage MD Buyline's Hippocrates powered by IBM Watson (a cognitive computing application) in its hospitals to enable better patient care, satisfaction and outcomes through more informed decision making.

10 Dec 2013

Adocia gets development and commercialization rights in nanotechnology for drug delivery

Adocia, a biotechnology company specializing in the development of ‘best-in-class’ medicines from already approved therapeutic proteins, announces today the signature of an exclusive license agreement with the CNRS, the University Bordeaux I, the Institut Polytechnique de Bordeaux and Aquitaine Science Transfert.

9 Dec 2013

Atonomics reaches agreement to advance development of diagnostic test for lifestyle diseases

Atonomics announces today that it has entered into an agreement with Omron Healthcare, which will enable Atonomics to advance the development of the AtolyzerConsumer device for advanced diagnostic testing of lifestyle diseases in a consumer pharmacy setting. As part of the transaction Omron Healthcare is taking a minority equity stake in Atonomics.

9 Dec 2013

Gecko Biomedical announces closing of Series A financing round

Gecko Biomedical, a privately owned medical device company based in Paris that is developing novel biodegradable surgical wound closure solutions, announced the closing of a €8 million ($11m) Series A financing round. The financing was co-led by Omnes Capital and CM-CIC Capital Finance, and joined by CapDecisif Management.

9 Dec 2013

NewLeaf Symbiotics announces acquisition of Intuitive Genomics

NewLeaf Symbiotics Inc. an agricultural biotech company, today announced the acquisition of Intuitive Genomics Inc., a leader in the design and implementation of custom bioinformatics solutions.

9 Dec 2013

Covidien signs definitive agreement to acquire outstanding shares of Given Imaging

Covidien plc and Given Imaging Ltd. today announced a definitive agreement under which Covidien will acquire all of the outstanding shares of Given Imaging for $30.00 per share in cash, for a total of approximately $860 million, net of cash and investments acquired. This transaction provides Covidien additional scale and scope to serve the multibillion dollar global gastrointestinal market and supports the Company's strategy to comprehensively address key global specialties and procedures.

8 Dec 2013

PhotoMedex terminates exclusive distribution agreement between Radiancy and Ya-Man in Japan

PhotoMedex, Inc. announced today the termination of the exclusive distribution agreement between its wholly-owned subsidiary Radiancy, Inc. and Ya-Man Ltd. for the Japanese market due to, among other things, disputed marketing expenses of approximately $1 million and the failure of Ya-Man to meet its minimum purchase obligations under the agreement.

6 Dec 2013

Kolltan Pharmaceuticals signs license agreement with University of Toronto for novel anti-KIT antibodies

Kolltan Pharmaceuticals, a privately held biopharmaceutical company, today announced the Company has signed a license agreement with the University of Toronto for novel anti-KIT receptor tyrosine kinase antibodies identified in the laboratories of Dr. Sachdev Sidhu at the University of Toronto and the laboratory of Dr. Joseph Schlessinger of Yale University.

6 Dec 2013

The Medicines Company, Boston Scientific announce co-promotion agreement for Promus PREMIER stent system

Boston Scientific Corporation and The Medicines Company announce a co-promotion agreement for the Boston Scientific Promus PREMIER™ Everolimus-Eluting Platinum Chromium Coronary Stent System.

6 Dec 2013

Business / Finance

Emergent BioSolutions enters into definitive agreement to acquire Cangene

Avinger closes significant funding round to initiate clinical trial on peripheral atherectomy catheter

Crealta to acquire all assets of Savient Pharmaceuticals

Pfizer, Octapharma AG to market investigational agent for urgent reversal of vitamin K antagonist

Vestiage selects ROI Media for direct to consumer marketing campaign

Broad Medical Research Program, Crohn's & Colitis Foundation of America to merge together

Patterson Companies announces quarterly cash dividend of $0.16 per share

Omega Protein proposes to streamline Gulf of Mexico operations

LEC announces consolidated financial results for Q2 2014

Echo Therapeutics signs strategic collaboration agreement with MTIA

INVISTA joins CPI for development of new technologies to enable gas-fermentation-based processes

Methodist Health System joins with IBM Watson and MD Buyline to enable better patient care

Adocia gets development and commercialization rights in nanotechnology for drug delivery

Atonomics reaches agreement to advance development of diagnostic test for lifestyle diseases

Gecko Biomedical announces closing of Series A financing round

NewLeaf Symbiotics announces acquisition of Intuitive Genomics

Covidien signs definitive agreement to acquire outstanding shares of Given Imaging

PhotoMedex terminates exclusive distribution agreement between Radiancy and Ya-Man in Japan

Kolltan Pharmaceuticals signs license agreement with University of Toronto for novel anti-KIT antibodies

The Medicines Company, Boston Scientific announce co-promotion agreement for Promus PREMIER stent system

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News